Pfizer CEO Attempts To Fearmonger Over Trump Administration’s Vaccine Policies

At the JPM Healthcare Conference, Pfizer’s Albert Bourla took a highly politicized stance, asserting without substantial evidence that a shift in vaccine strategy under the Trump administration would lead to a public health disaster. This alarmist message seems aimed more at promoting Pfizer’s financial interests than at discussing the merits of a more diversified approach to public health and vaccine distribution.